<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               2 DOSAGE AND ADMINISTRATION<BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           Recommended dose:  960 mg orally twice daily. (2.1)<BR>                           Administer ZELBORAF approximately 12 hours apart with or without a meal. (2.1)<BR>                           ZELBORAF should be swallowed whole with a glass of water.  ZELBORAF should not be chewed or crushed. (2.1)<BR>                           Management of symptomatic adverse drug reactions may require dose reduction, treatment interruption, or treatment discontinuation of ZELBORAF. Dose reductions resulting in a dose below 480 mg twice daily are not recommended. (2.2)<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.1	Recommended Dose<BR>                     <BR>                        The recommended dose of ZELBORAF is 960 mg (four 240 mg tablets) twice daily. The first dose should be taken in the morning and the second dose should be taken in the evening approximately 12 hours later. Each dose can be taken with or without a meal. <BR>                        ZELBORAF tablets should be swallowed whole with a glass of water. ZELBORAF tablets should not be chewed or crushed.<BR>                     <BR>                     <BR>                     <BR>                        <BR>                           <BR>                           <BR>                           <BR>                              <BR>                                 Duration of treatment<BR>                              <BR>                              It is recommended that patients are treated with ZELBORAF until disease progression or unacceptable toxicity occurs.<BR>                           <BR>                           <BR>                        <BR>                     <BR>                     <BR>                        <BR>                           <BR>                           <BR>                           <BR>                              <BR>                                 Missed doses<BR>                              <BR>                              If a dose is missed, it can be taken up to 4 hours prior to the next dose to maintain the twice daily regimen. Both doses should not be taken at the same time.<BR>                           <BR>                           <BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     2.2	Dose Modifications<BR>                     <BR>                        Management of symptomatic adverse drug reactions or prolongation of QTc may require dose reduction, treatment interruption, or treatment discontinuation of ZELBORAF (Table 1). Dose modifications or interruptions are not recommended for cutaneous squamous cell carcinoma (cuSCC) adverse reactions [see Warnings and Precautions (5.1) and Adverse Reactions (6.1)]. Dose reductions resulting in a dose below 480 mg twice daily are not recommended.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" width="100%" ID="table1"><BR>                           <caption>Table 1     Dose Modification Information</caption><BR>                           <col width="30%" align="left" valign="top"/><BR>                           <col width="70%" align="left" valign="top"/><BR>                           <thead><BR>                              <tr><BR>                                 <th styleCode="Lrule Rrule" align="center">Grade (CTC-AE)<footnote>The intensity of clinical adverse events graded by the Common Terminology Criteria for Adverse Events v4.0 (CTC-AE)</footnote><BR>                                 </th><BR>                                 <th styleCode="Rrule" align="center">Recommended ZELBORAF  Dose Modification</th><BR>                              </tr><BR>                           </thead><BR>                           <tbody><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Grade 1 or Grade 2 (tolerable) </content><BR>                                 </td><BR>                                 <td styleCode="Rrule">Maintain ZELBORAF at a dose of  960 mg twice daily.</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Grade 2 (Intolerable) or Grade 3</content><BR>                                 </td><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">&#160;&#160;1<sup>st</sup> Appearance</td><BR>                                 <td styleCode="Rrule">Interrupt treatment until grade 0 &#8211; 1. Resume dosing at 720 mg twice daily.</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">&#160;&#160;2<sup>nd</sup> Appearance</td><BR>                                 <td styleCode="Rrule">Interrupt treatment until grade 0 &#8211; 1. Resume dosing at 480 mg twice daily. </td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">&#160;&#160;3<sup>rd</sup> Appearance</td><BR>                                 <td styleCode="Rrule">Discontinue  permanently</td><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule"><BR>                                    <content styleCode="bold">Grade 4</content><BR>                                 </td><BR>                                 <td styleCode="Rrule"/><BR>                              </tr><BR>                              <tr styleCode="Botrule"><BR>                                 <td styleCode="Lrule Rrule">&#160;&#160;1<sup>st</sup> Appearance</td><BR>                                 <td styleCode="Rrule">Discontinue permanently or interrupt ZELBORAF treatment until grade 0 &#8211; 1.<br/>Resume dosing at 480 mg twice daily.</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule">&#160;&#160;2<sup>nd</sup> Appearance</td><BR>                                 <td styleCode="Rrule">Discontinue permanently</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                     <BR><BR><BR><BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>